ZyVersa Therapeutics (ZVSA) Competitors $0.16 -0.01 (-7.51%) As of 03:16 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZVSA vs. CMND, ONCO, JAGX, PWUP, TRIB, REVB, GRI, EVAX, SHPH, and CNSPShould you be buying ZyVersa Therapeutics stock or one of its competitors? The main competitors of ZyVersa Therapeutics include Clearmind Medicine (CMND), Onconetix (ONCO), Jaguar Animal Health (JAGX), PowerUp Acquisition (PWUP), Trinity Biotech (TRIB), Revelation Biosciences (REVB), GRI Bio (GRI), Evaxion A/S (EVAX), Shuttle Pharmaceuticals (SHPH), and CNS Pharmaceuticals (CNSP). These companies are all part of the "pharmaceutical products" industry. ZyVersa Therapeutics vs. Its Competitors Clearmind Medicine Onconetix Jaguar Animal Health PowerUp Acquisition Trinity Biotech Revelation Biosciences GRI Bio Evaxion A/S Shuttle Pharmaceuticals CNS Pharmaceuticals ZyVersa Therapeutics (NASDAQ:ZVSA) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings. Which has higher earnings & valuation, ZVSA or CMND? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZyVersa TherapeuticsN/AN/A-$9.41MN/AN/AClearmind MedicineN/AN/A-$5.26M-$0.76-1.34 Which has more volatility and risk, ZVSA or CMND? ZyVersa Therapeutics has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Do insiders and institutionals believe in ZVSA or CMND? 3.9% of ZyVersa Therapeutics shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 0.2% of ZyVersa Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer ZVSA or CMND? In the previous week, Clearmind Medicine had 2 more articles in the media than ZyVersa Therapeutics. MarketBeat recorded 3 mentions for Clearmind Medicine and 1 mentions for ZyVersa Therapeutics. Clearmind Medicine's average media sentiment score of 1.42 beat ZyVersa Therapeutics' score of 0.31 indicating that Clearmind Medicine is being referred to more favorably in the news media. Company Overall Sentiment ZyVersa Therapeutics Neutral Clearmind Medicine Positive Is ZVSA or CMND more profitable? ZyVersa Therapeutics' return on equity of -109.54% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets ZyVersa TherapeuticsN/A -109.54% -43.95% Clearmind Medicine N/A -173.87%-70.55% SummaryClearmind Medicine beats ZyVersa Therapeutics on 5 of the 8 factors compared between the two stocks. Get ZyVersa Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ZVSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZVSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZVSA vs. The Competition Export to ExcelMetricZyVersa TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.31M$3.13B$5.73B$10.29BDividend YieldN/A2.36%5.88%4.63%P/E RatioN/A21.1777.0026.56Price / SalesN/A450.43525.94121.18Price / CashN/A45.4037.2060.52Price / Book0.059.5413.936.32Net Income-$9.41M-$53.02M$3.29B$271.37M7 Day Performance0.36%0.44%0.72%2.19%1 Month Performance6.87%4.00%4.41%6.80%1 Year Performance-93.32%8.57%84.19%27.95% ZyVersa Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZVSAZyVersa Therapeutics0.2626 of 5 stars$0.17-7.5%N/A-92.5%$1.31MN/A0.002Gap DownCMNDClearmind Medicine1.4118 of 5 stars$1.03+2.1%N/A-24.1%$4.40MN/A-0.94N/AEarnings ReportShort Interest ↓Gap UpONCOOnconetix0.8912 of 5 stars$2.78+3.7%N/A-99.2%$4.30M$1.33M0.0012JAGXJaguar Animal Health1.6461 of 5 stars$1.93-2.5%$60.00+3,008.8%-92.8%$4.19M$11.69M0.0050Short Interest ↑PWUPPowerUp AcquisitionN/A$0.510.0%N/A-96.4%$3.97MN/A0.00N/AHigh Trading VolumeTRIBTrinity Biotech1.5188 of 5 stars$1.10-1.8%N/A-85.2%$3.97M$61.56M-0.08480Gap DownREVBRevelation Biosciences0.8538 of 5 stars$2.33-17.4%N/A-96.3%$3.96MN/A-0.0310News CoverageGap DownHigh Trading VolumeGRIGRI Bio3.0197 of 5 stars$1.57+0.6%$22.00+1,301.3%-77.6%$3.96MN/A-0.141Short Interest ↓Gap UpEVAXEvaxion A/S2.5551 of 5 stars$2.80-5.1%$10.00+257.1%-81.9%$3.92M$3.34M-2.1260News CoverageGap UpSHPHShuttle Pharmaceuticals1.5486 of 5 stars$3.50+4.5%N/A-91.5%$3.75MN/A-0.845News CoverageShort Interest ↓Gap DownCNSPCNS Pharmaceuticals1.799 of 5 stars$6.54+2.3%$300.00+4,490.7%-90.0%$3.73MN/A0.005Short Interest ↑ Related Companies and Tools Related Companies CMND Alternatives ONCO Alternatives JAGX Alternatives PWUP Alternatives TRIB Alternatives REVB Alternatives GRI Alternatives EVAX Alternatives SHPH Alternatives CNSP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZVSA) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZVSA Stock Alerts